{"id":"W4399395212","doi":"10.1200/jco.24.00720","title":"Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein–Overexpressing Advanced Nonsquamous <i>EGFR</i> -Wildtype Non–Small Cell Lung Cancer in the Phase II LUMINOSITY Trial","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":135,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Hôpital Charles-Le Moyne","funders":"Aptitude Health","keywords":"Medicine; Internal medicine; Oncology; Clinical endpoint; Population; Lung cancer; Phases of clinical research; non-small cell lung cancer (NSCLC); Chemotherapy; Gastroenterology; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001138404,0.0002142046,0.001065033,0.0001809686,0.00007158919,0.00002999799,0.0001767748,0.0002406714,0.00005755156],"category_scores_gemma":[0.0001954938,0.0001174629,0.0002497142,0.0003602581,0.00009525743,0.0001845488,0.00002416279,0.001011355,0.000001973699],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000650997,"about_ca_system_score_gemma":0.002784647,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000223442,"about_ca_topic_score_gemma":0.0003132065,"domain_scores_codex":[0.9970527,0.0004047277,0.001598929,0.0002975321,0.0003409581,0.0003052127],"domain_scores_gemma":[0.9980318,0.0006335204,0.0007667051,0.0002116709,0.0001968816,0.0001594357],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2780629,0.02915448,0.2068748,0.0002788712,0.0008191992,0.001856981,0.004239378,0.0005714021,0.0006150464,0.00001120457,0.001256598,0.4762591],"study_design_scores_gemma":[0.7172253,0.1398503,0.1106575,0.002976482,0.002224663,0.00004492424,0.0003307053,0.001029024,0.0005757748,0.00005503544,0.02462158,0.0004086875],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9925658,0.00199096,0.0000642675,0.001280709,0.000589821,0.002589173,0.000018899,0.00001289777,0.0008875228],"genre_scores_gemma":[0.9966645,0.0003458526,0.001361365,0.0007348515,0.0004865533,0.00013809,0.00001177266,0.00003075515,0.0002262994],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4758505,"threshold_uncertainty_score":0.4939845,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03374558598530639,"score_gpt":0.442970732632129,"score_spread":0.4092251466468226,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}